Friday, July 10, 2026

pharma · Infertility in women undergoing assisted reproductive technologies (ART) · Intermediate risk, non-muscle invasive bladder cancer

Ferring Pharmaceuticals

Ferring Pharmaceuticals is a pharma organization headquartered in Mumbai, IN. Primary therapeutic focus areas include Infertility in women undergoing assisted reproductive technologies (ART), Intermediate risk, non-muscl

-, St-Prex, 1162, CH, Mumbai HQ
1950 Founded
6,228 Employees
NMPA registrant Type
Company details
Status
Public
HQ
-, St-Prex, 1162, CH, Mumbai
Founded
1950
Employees
6,228
Programs
13
Drugs
23
Patents
0
Clinical program

REKOVELLE for Idiopathic male infertility (in…

Phase 2 · small molecule · Idiopathic male infertility (including oligoasthenozoospermia).

REKOVELLE for Idiopathic male infertility (in… for Idiopathic male infertility (including oligoasthenozoospermia). is a Phase 2 program (small_molecule) at Ferring Pharmaceuticals with 1 ClinicalTrials.gov record(s).

← All Ferring Pharmaceuticals projects Phase 2 small molecule active

Full intelligence profile for this program is being prepared.

At a glance

Sponsor
Ferring Pharmaceuticals
Phase
Phase 2
Modality
small_molecule
Indication
Idiopathic male infertility (including oligoasthenozoospermia).
Status
active
Trials
1